Gene Editing Technologies

  In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting , to treat a wide range of clinical conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “ RNA Targeting Small Molecules Therapeutics Market ”   The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:   §   An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical sta...

  To order this 150+ page report, which features 100+ figures and 5+ tables, please visit https://www.rootsanalysis.com/reports/gene-editing-market.html   Key Inclusions §   A detailed assessment of the current market landscape of ZFNs based therapies, based on several relevant parameters, such as phase of development (clinical and preclinical), biological target(s) (BCL 11A, C9ORF72, CD 19, HLA-A2, HTT gene, MAPT, SNCA gene, VEGF-A, HPV16/E7 and HPV18/E7), delivery vehicle (non-viral and naked plasmid), target indication(s), therapeutic area(s) (Blood Disorders, Infectious Diseases, Neurological Disorders, Oncological Disorders and Others) and type of therapy (in-vivo and ex-vivo). In addition, it provides details on the companies engaged in the development of ZFNs based therapies, along with information on their year of establishment, company size and location of headquarters. §   A detailed assessment of the current market landscape of TALENs based thera...